DR. MAHMOUD EL-TAMER, M.D.
Medical Practice at 66 St, New York, NY
License number
New York 193945-1
Category
Medical Practice
Type
Specialist
Address
Address
300 E 66Th St, New York, NY 10065
Phone
(646) 888-4753
(646) 888-4921 (Fax)
(646) 888-4755
(646) 888-4921 (Fax)
(646) 888-4755
Organization information
See more information about MAHMOUD EL-TAMER at bizstanding.comMahmoud El-Tamer MD
161 Ft Washington Ave, New York, NY 10032
Industry:
Surgeons
Phone:
(212) 305-0728 (Phone)
Mahmoud Bahij El-Tamer
Professional information
See more information about MAHMOUD EL-TAMER at trustoria.com
Dr. Mahmoud El-Tamer, New York NY - MD (Doctor of Medicine)
Dr. Mahmoud El-Tamer, New York NY - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
Procedures:
Biopsy of Breast, Excision of Breast Tumor, Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Lymph Node Biopsy or Excision, Mastectomy, Port Placements or Replacements, Removal or Destruction of Rectal or Intestinal Tumor (incl. Colonoscopy, Proctosigmoidoscopy, Sigmoidoscopy & Control of Hemorrhage)
Conditions:
Breast Cancer, Breast Lump/Mass, Carcinoma in Situ, Cholecystitis and Gallstones, Colorectal Cancer, Crohn's Disease (Regional Enteritis), Diaphragmatic/Hiatal Hernia, Hemorrhoids, Hyperparathyroidism, Lipomas, Lung Cancer, Peripheral Vascular Disease (PAD, PVD), Phlebitis and Thrombophlebitis, Secondary Malignancies, Soft Tissue Sarcoma, Ulcerative Colitis, Umbilical Hernia, Varicose Veins, Ventral Hernia
Certifications:
General Surgery, 2001
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
1275 York Ave, New York 10065
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Education:
Medical School
American University Of Beirut, Faculty Of Medicine
Graduated: 1981
American U Hosp
Suny-Hscb
Meml Sloan-Kettering
American University Of Beirut, Faculty Of Medicine
Graduated: 1981
American U Hosp
Suny-Hscb
Meml Sloan-Kettering
Mahmoud El-Tamer, New York NY
Mahmoud El-Tamer, New York NY
Specialties:
Surgeon
Address:
161 Fort Washington Ave, New York, NY 10032
1275 York Ave, New York, NY 10065
300 E 66Th St, New York, NY 10065
1275 York Ave, New York, NY 10065
300 E 66Th St, New York, NY 10065
Education:
American University of Beirut, Faculty of Medicine - Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Surgical Oncology
SUNY State University Hospital of Brooklyn - Residency - Surgery
American University of Beirut Medical Center - Residency - Surgery
Memorial Sloan-Kettering Cancer Center - Fellowship - Surgical Oncology
SUNY State University Hospital of Brooklyn - Residency - Surgery
American University of Beirut Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Detectably Labeled Porphyrin Compound For Identifying The Sentinel Lymph Node
Detectably Labeled Porphyrin Compound For Identifying The Sentinel Lymph Node
US Patent:
6458336, Oct 1, 2002
Filed:
May 30, 2000
Appl. No.:
09/583359
Inventors:
Mahmoud El-Tamer - New York NY
Rashid Fawaz - New York NY
Theodore Wang - Tenafly NJ
Ted Chaglassian - Forrest Hills NY
Rola Saouaf - New York NY
Rashid Fawaz - New York NY
Theodore Wang - Tenafly NJ
Ted Chaglassian - Forrest Hills NY
Rola Saouaf - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 5100
US Classification:
424 165, 424 91, 424 961
Abstract:
A detectably labeled porphyrin compound for identifying a sentinel lymph node in patients, particularly those with cancer. A method of identifying a sentinel lymph node, comprising the steps of: injecting the detectably labeled porphyrin compound into a tumor, wherein the porphyrin compound is detectably labeled with a radiolabel which is a -emitting radioactive metal; and detecting radioactive emission or a color so as to detect and thereby identify the sentinel lymph node. A method of identifying a sentinel lymph node, comprising the steps of injecting the detectably labeled porphyrin compound into tissue surrounding a tumor, wherein the porphyrin compound is detectably labeled with a non-radioactive metal; and taking a series of magnetic resonance images to identify the sentinel lymph node by viewing the images showing the injected detectably labeled porphyrin compound.
Detectably Labeled Porphyrin Compound For Identifying The Sentinel Lymph Node
Detectably Labeled Porphyrin Compound For Identifying The Sentinel Lymph Node
US Patent:
7198775, Apr 3, 2007
Filed:
Jul 19, 2002
Appl. No.:
10/199660
Inventors:
Mahmoud El-Tamer - New York NY, US
Rashid Fawaz - New York NY, US
Theodore Wang - Tenafly NJ, US
Ted Chaglassian - Forrest Hills NY, US
Rola Saouaf - New York NY, US
Rashid Fawaz - New York NY, US
Theodore Wang - Tenafly NJ, US
Ted Chaglassian - Forrest Hills NY, US
Rola Saouaf - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61B 5/055
US Classification:
424 9362, 424 91, 424 93, 424 9361
Abstract:
A detectably labeled porphyrin compound for identifying a sentinel lymph node in patients, particularly those with cancer. A method of identifying a sentinel lymph node, comprising the steps of: injecting the detectably labeled porphyrin compound into a tumor, wherein the porphyrin compound is detectably labeled with a radiolabel which is a γ-emitting radioactive metal; and detecting radioactive emission or a color so as to detect and thereby identify the sentinel lymph node. A method of identifying a sentinel lymph node, comprising the steps of injecting the detectably labeled porphyrin compound into tissue surrounding a tumor, wherein the porphyrin compound is detectably labeled with a non-radioactive metal; and taking a series of magnetic resonance images to identify the sentinel lymph node by viewing the images showing the injected detectably labeled porphyrin compound.